• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Warfarin vs non ‐vitamin K oral anticoagulants for left atrial appendage thrombus: A meta‐analysis
ConclusionThe results of our meta ‐analysis show that NOACs are as efficacious and safe as warfarin in the treatment of left atrial appendage thrombus in patients with non‐valvular atrial fibrillation.
Source: Journal of Cardiovascular Electrophysiology - May 5, 2020 Category: Cardiology Authors: Ghulam Murtaza, Mohit K. Turagam, Varunsiri Atti, Jalaj Garg, Urooge Boda, Poonam Velagapudi, Krishna Akella, Andrea Natale, Rakesh Gopinathannair, Dhanunjaya Lakkireddy Tags: ORIGINAL ARTICLES Source Type: research

Warfarin versus non ‐vitamin K oral anticoagulants for left atrial appendage thrombus: A meta‐analysis
ConclusionThe results of our meta ‐analysis show that NOACs are as efficacious and safe as warfarin in the treatment of LAA thrombus in patients with non‐valvular AF.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - April 21, 2020 Category: Cardiology Authors: Ghulam Murtaza, Mohit K. Turagam, Varunsiri Atti, Jalaj Garg, Urooge Boda, Poonam Velagapudi, Krishna Akella, Andrea Natale, Rakesh Gopinathannair, Dhanunjaya Lakkireddy Tags: ORIGINAL ARTICLES Source Type: research

Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: a population ‐based study
ConclusionIn this real world, population ‐based cohort of patients with newly diagnosed AF, we found a lower than expected rate of OAC prescription within 3 months of diagnosis but an encouraging increase in OAC purchasing over time. Use of NOACs has risen exponentially in only a few years, accounting for a greater pool of AF patients be ing prescribed an OAC.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - March 25, 2020 Category: Cardiology Authors: Louise Kezerle, Meytal Avgil Tsadok, Adi Berliner Senderey, Moshe Hoshen, Maya Leventer ‐Roberts, Orna Reges, Morton Leibowitz, Moti Haim Tags: ORIGINAL ARTICLE Source Type: research

Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - September 12, 2019 Category: Cardiology Authors: Eric Black ‐Maier, Jonathan P. Piccini, Christopher Granger Tags: POINT OF VIEW Source Type: research

Augmented Intelligence Decision Tool for Stroke Prediction Combines Factors from CHA2DS2 ‐VASc and the Intermountain Risk Score for Patients with Atrial Fibrillation
ConclusionsA temporally dynamic risk score, IMRS ‐VASc was derived and validated as a predictor of stroke in AF outpatients. IMRS‐VASc requires further validation and the evaluation of its use in guiding care and treatment decisions for AF patients.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - May 21, 2019 Category: Cardiology Authors: Benjamin D. Horne, Victoria Jacobs, Heidi T. May, Kevin G. Graves, T. Jared Bunch Tags: ORIGINAL ‐ CLINICAL Source Type: research

Long ‐term aspirin does not lower risk of stroke and increases bleeding risk in low‐risk atrial fibrillation ablation patients
ConclusionsAfter catheter ablation, low risk patients do not benefit from long‐term aspirin therapy, but are at risk for higher rates of bleeding when compared to no therapy or warfarin.
Source: Journal of Cardiovascular Electrophysiology - September 26, 2017 Category: Cardiology Authors: Victoria Jacobs, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler DO, John D. Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch Tags: ORIGINAL ARTICLE Source Type: research

Long ‐term aspirin does not lower risk of stroke and increases bleeding risk in low risk atrial fibrillation ablation patients
Conclusions: After catheter ablation, low risk patients do not benefit from long‐term aspirin therapy, but are at risk for higher rates of bleeding when compared to no therapy or warfarin.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - August 1, 2017 Category: Cardiology Authors: Victoria Jacobs, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler DO, John D. Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch Tags: ORIGINAL ARTICLE Source Type: research

Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)
ConclusionIn WI patients rechallenged with DOACs, a significant proportion developed repeat MBE. LAAO devices seem reasonable in those patients who undergo major interventions to manage MBE with cautious and temporary continuation of DOAC.
Source: Journal of Cardiovascular Electrophysiology - June 8, 2017 Category: Cardiology Authors: Mohit K. Turagam, Valay Parikh, Muhammad R. Afzal, Rakesh Gopinathannair, Madhav Lavu, Arun Kanmanthareddy, Jayasree Pillarisetti, Madhu Reddy, Donita Atkins, Sudharani Bommana, Melissa Jaeger, Courtney Jeffery, Sanghamitra Mohanty, Pasquale Santangeli, J Tags: ORIGINAL ARTICLE Source Type: research

Replacing warfarin with a novel oral anticoagulant ‐ risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)
ConclusionIn WI patients re‐challenged with DOACs, a significant proportion developed repeat MBE. LAAO devices seem reasonable in those patients who undergo major interventions to manage MBE with cautious and temporary continuation of DOAC.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - April 1, 2017 Category: Cardiology Authors: Mohit K. Turagam, Valay Parikh, Muhammad R. Afzal, Rakesh Gopinnathanair, Madhav Lavu, Arun Kanmanthareddy, Jayasree Pillarisetti, Madhu Reddy, Donita Atkins, Sudharani Bommana, Melissa Jaeger, Courtney Jeffery, Sanghamitra Mohanty, Pasquale Santangeli, J Tags: ORIGINAL ARTICLE Source Type: research

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study
Conclusion: Apixaban has similar safety and effectiveness to warfarin for the prevention of cerebral thromboembolism during the periprocedural period of AF ablation.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - January 13, 2016 Category: Cardiology Authors: TAISHI KUWAHARA, MITSUNORI ABE, MASARU YAMAKI, HIROYUKI FUJIEDA, YUMIKO ABE, KATSUSHI HASHIMOTO, MISAKO ISHIBA, HIROTSUKA SAKAI, KEIICHI HISHIKARI, MASATERU TAKIGAWA, KENJI OKUBO, KATSUMASA TAKAGI, YASUAKI TANAKA, JUN NAKAJIMA, ATSUSHI TAKAHASHI Tags: Original Source Type: research

Periprocedural Stroke Risk in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Warfarin
ConclusionsIn contrast to existing data, periprocedural stroke still occurs despite therapeutic anticoagulation throughout the operative period. The optimal strategy to protect patients against thromboembolic stroke remains unclear.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - March 1, 2014 Category: Cardiology Authors: STEPHEN P. PAGE, NEIL HERRING, ROSS J. HUNTER, EMMA WITHYCOMBE, MATTHEW LOVELL, G. WALI, TIMOTHY R. BETTS, YAVER BASHIR, MEHUL DHINOJA, MARK J. EARLEY, SIMON C. SPORTON, KIM RAJAPPAN, RICHARD J. SCHILLING Tags: Original Article Source Type: research

AF News
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - March 1, 2014 Category: Cardiology Authors: TZE‐FAN CHAO, LI‐WEI LO, SHIH‐ANN CHEN Tags: AF News Source Type: research

Dabigatran Versus Warfarin Therapy For Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
ConclusionThe administration of dabigatran is as safe and effective as warfarin for uninterrupted OA therapy during catheter ablation of AF.
Source: Journal of Cardiovascular Electrophysiology - March 15, 2013 Category: Cardiology Authors: WILLIAM MADDOX, G. NEAL KAY, TAKUMI YAMADA, JOSE OSORIO, HARISH DOPPALAPUDI, VANCE J. PLUMB, ALICIA GUNTER, H. THOMAS MCELDERRY Tags: Original Clinical Source Type: research